FTC Hits Lumosity With Fine for Deceptive Brain Health Ads
You’ve probably seen or heard ads for the brain training app Lumosity boasting that its games were designed by neuroscientists and were scientifically proven to help stave off Alzheimer’s as well as improve real-world cognitive performance. Well, you won’t be seeing those ads anymore. Lumosity maker Lumo Labs are now banned from making such claims as the result of a multimillion-dollar settlement with the Federal Trade Commission, the agency said today.
Other Articles in this Edition
ADHD Meds May Raise Risk for Psychotic Side Effects in Some Kids: Study
Psychotic Symptoms in Children on Stimulants. What are the Implications for the Clinician?
Study finds no increased risk of autism, ADHD with prenatal antidepressant exposure
Techniques for working with ADD team members
10 Ways to Make the Most of a Child’s IEP Meeting